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Objective: To assess the nutritional status of child and adolescent patients with cancer at
diagnosis.
Methods: A total of 1154 patients were included and divided into two groups: solid and
hematological malignancies. The parameters used for nutritional assessment were
weight, height, triceps skinfold thickness, mid-upper arm circumference, arm muscle
circumference,  body mass index and percentage weight loss.
Results: At diagnosis, below adequate body mass index was observed by anthropomet-
ric  analysis in 10.85% of the patients – 12.2% in the solid tumor group and 9.52% in the
hematologic group. The average weight loss adjusted for a period of 7 days was −2.82% in
the  hematologic group and −2.9% in the solid tumor group.
Conclusions: The prevalence of malnutrition is higher among patients with malignancies
than in the general population, even though no difference was observed between the two
groups.©  2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.
populations in 2012.3Introduction
Pediatric malignancies account for between 1% and 3% of can-
cer diagnosed worldwide.1 However, in developing countries,
where the proportion of children and adolescents is about
50% of the population, these tumors correspond to from 3% to
10% of all malignant neoplasms;2 in developed countries this
rate is about 1%. According to the Population-Based Cancer
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reserved.Registers (RCBP), the incidence of pediatric tumors in Brazil
is between developing and developed countries, accounting
for 3% of all malignancies. As nearly 30% of the population is
19 years old or less, it is estimated that approximately 11,530
new cases of cancer occurred in the pediatric and adolescentento de Pediatria, Universidade Federal de São Paulo (UNIFESP),
The prevalence of malnutrition among these patients
varies from 10% to 50% depending on the assessment method
 e Terapia Celular. Published by Elsevier Editora Ltda. All rights
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sed, time of evaluation (at diagnosis, during chemotherapy,
tc.), tumor stage and histology type, and patient socioeco-
omic status.4–12
Considering the importance of knowing the nutritional sta-
us of pediatric patients with malignant neoplasms, this study
as performed with the following objectives:
 To evaluate the nutritional state of under 20-year-old cancer
patients at diagnosis;
 To compare the nutritional status of patients with solid
tumors (ST) to those with hematological malignancies (HM);
 To correlate the diagnosis with the nutritional status of the
patient, the caregiver’s level of education, family income
and place of origin.
ethods
his transversal observational study evaluated the nutritional
tatus of 1154 consecutive children and teenagers with malig-
ant neoplasms treated in the outpatient clinic or admitted
s inpatients on the wards or in the intensive care units of
he Pediatric Oncology Institute of the Pediatrics Department,
niversidade Federal de São Paulo (UNIFESP), from March 2006
o March 2012. This study was approved by the Research Ethics
ommittee of UNIFESP.
Patients aged 0–19 years with diagnosis of malignant neo-
lasms or benign tumors of the central nervous system
ith malignant behavior (i.e. craniopharyngioma, astrocy-
oma, etc.) were enrolled in this study. Patients with history
f treatment of the neoplasm, receiving corticosteroids, those
ith chronic pre-existent diseases or with physical limitations
hat would hinder adequate measurement of study variables
in particular height and weight) were excluded.
The patients were divided into two groups according to
iagnosis: HM group, comprising lymphoma and leukemia,
nd the ST group, which included all other tumors.
The Anthro software of the World Health Organization
version 3.0.1; Department of Nutrition, WHO) was used to
alculate the nutritional status according to the body mass
ndex (BMI) of up to 5-year-old patients and the WHO  Anthro-
lus software (version 1.0.2) for patients aged more  than 5
ears. Nutritional status was classiﬁed according to the WHO
13,14riteria and then categorized into three groups:
 Below adequate – patients with a z-score more  than two
standard deviations (SD) below the mean BMI  for age;
Table 1 – Demographic data of patients with cancer at the time 
Hematological tumo
n (%) 373 (32.49) 
Age – median (mean ± standard deviation) 8.90 (10.33 ± 9.51
Gender – male (%) 54 
Mean family income (R$) 129.00 
Illiteracy rate of caregiver – n (%) 13 (3.48) 
Student’s t-test: the groups did not differ in relation to gender, age, educat 1 4;3  6(6):420–423 421
- Adequate – patients with a z-score between two  SD below
and one SD above the mean BMI for age;
- Above adequate – patients with a z-score more  than one SD
above the mean BMI for age.
The parameters used for nutritional assessment were
weight, height, triceps skinfold thickness (TSFT), mid-upper
arm circumference (MUAC) and arm muscle circumference
(AMC), BMI and percentage weight loss. TSFT, MUAC and AMC
were classiﬁed according to the classiﬁcation of Frisancho15
as follows:
- Below adequate: ≤5th percentile;
- Adequate: between 5th and 95th percentiles;
- Above adequate: ≥95th percentile.
Weight loss was qualitatively evaluated by questioning the
patient or caregiver about whether they had noticed weight
loss and quantitatively assessed by the absolute difference
between the usual weight of the patient (as reported by the
patient/caregiver) and the weight on admission. The relative
weight loss was obtained by dividing the weight lost by the
usual weight and classiﬁed according to the time of occur-
rence (as reported by the caregiver) using the Blackburn et al.
formula,16 adjusted for a 7-day period.
Statistical  analysis
The Chi-square test was used to assess the association
between oncologic diagnosis and prevalence of nutritional
deﬁcit as identiﬁed by the TSFT, MUAC, and AMC  exams.
The nonparametric Kruskal–Wallis test was used to assess
the association between diagnosis and weight loss and
between diagnosis and nutritional deﬁcit as measured by
the BMI. The signiﬁcance threshold (˛) was set at 5% (p-
value < 0.05).
Results
A total of 1317 patients were admitted to the intensive care
units and inpatient facilities or treated in the outpatient clinic
during the study period. Of those, 163 were excluded from
analysis due to difﬁculties in weighing or the imprecision of
the result. Thus, 1154 patients were included in the study
of which 53.09% were male and the mean age was 10.24
years. The distribution of tumor types (HM and ST), age, fam-
ily income and education level of the caregiver is shown in
Table 1.
of diagnosis (n = 1154).
rs Solid tumors Total
781 (67.51) 1154 (100.00)
) 7.85 (9.84 ± 10.85) 8.10 (10.08 ± 10.05)
52 53
147.00 202.50
29 (3.71) 42 (3.63)
ion of caregiver and mean family income. 1 US$ is about R$ 2.23.
422  rev bras hematol hemoter.
Table 2 – Percentage of malnutrition according to
anthropometric parameters (n = 1154).
Anthropometric parameters
Hematological
tumors (%)
Solid tumors
(%)
Total (%)
Body mass index
<Adequate 9.52 12.2 10.85
Adequate 75.05 63.23 69.15
>Adequate 15.43 24.57 20.00
Triceps skinfold thickness
<Adequate 28.71 26.38 27.02
Adequate 68.64 70.85 70.24
>Adequate 2.64 2.76 2.72
Mid-upper arm circumference
<Adequate 22.03 25.78 24.74
Adequate 74.01 70.06 71.15
>Adequate 3.94 4.15 4.09
Arm muscle circumference
<Adequate 12.50 14.33 13.83
Adequate 80.59 78.23 78.88
>Adequate 6.90 7.42 7.27
Chi-squared test: groups did not differ with respect to the diagno-
sis of nutritional status according to the different anthropometric
parameters.
According to anthropometric analysis, 10.85% of the
patients presented with below adequate BMI at admission.
However, when the TSFT, MUAC and AMC  exams were used,
the prevalence of malnutrition increased to 27.02%, 24.74%
and 13.83%, respectively. The prevalences of malnutrition by
type of tumor and anthropometric parameter are shown in
Table 2.
Table 3 shows the mean weight loss adjusted to 7-day
periods: −2.82% in the patients of the HM group, and −2.9%
in the patients of the ST group (p-value = 0.11). No statisti-
cally signiﬁcant differences were observed in respect to usual
weight (p-value = 0.18) and current weight (p-value = 0.11)
between the two groups.Table 3 – Weight loss at diagnosis of patients with
hematological and solid tumors (n = 1154).
Hematological
tumors
Solid
tumors
Usual weight (kg)
Median (mean ± SD)
28.00  (33.88 ± 19.00) 25.00 (32.08 ± 21.00)
Weight at diagnosis
(kg)
Median (mean ± SD)
27.05  (32.66 ± 19.18) 24.5 (30.57 ± 20.39)
Weight loss (%)
(mean ± SD)
−2.82 ± 1.38 −2.90 ± 5.8
SD: Standard deviation.
Chi-squared test: the groups did not differ in mean usual weight,
weight at diagnosis and percentage weight loss. 2 0 1 4;3  6(6):420–423
Discussion
A signiﬁcant drop in the prevalence of malnutrition was
observed in Brazil during recent decades. The problem of low
weight for age has been practically overcome in under 5-year-
old children and the low height for age in this age group will
follow a similar trend over the next 10 years if the current rate
of reduction is maintained.17–24
One of the main reasons for this evolution is the improve-
ment in the organization of basic care by the Brazilian National
Healthcare System with the Family Healthcare Strategy. The
evolution of primary healthcare is central to guarantee access
and promote equity through closer contact of the population
with healthcare services and measures to promote health and
disease prevention.18–24
In this study, according to the BMI, the prevalence of malnu-
trition at the time of diagnosis was higher than in the general
Brazilian population. This is probably due to the catabolism
caused by the disease. The prevalence of malnutrition is also
higher than reported in the international literature, probably
due to the low income of the population.
Between 2000 and 2012, a 30% increase in the per capita
income was observed in the Brazilian population. In 2010, the
Brazilian per capita income was R$ 767.02, 80% higher than the
medium per capita of our patients.19–22 Interestingly, besides
the low income, the illiteracy rate (3.63%) among caregivers
was lower than in the general population (9.3%).20–23
The results of the current study suggest that some types of
tumors can mask malnutrition, mainly when only the BMI  is
used for evaluation. Therefore, other anthropometrical mea-
surements based on TSF and MUAC measurements must be
combined, as they more  efﬁciently evaluate body composi-
tion and diagnose malnutrition in patients with pediatric
cancer.18–24
The patients included in this study were not evaluated from
the beginning of the symptoms up to admission in our service.
Therefore, many  would have been evaluated by other profes-
sionals in other health centers, before their ﬁnal diagnosis and
their ﬁrst oncological consultation. In this study, nutritional
evaluation was performed at the time of diagnosis, which is
supposedly the most adequate time to prevent worsening of
the nutritional status. In other words, at ‘onset’ of the disease,
which is ideally the time when the oncological diagnosis is
made, the level of malnutrition is expected to be similar to
others in the population to which the patient belongs. Mal-
nutrition worsens as the tumor evolves, that is, the later the
diagnosis, the higher is the risk of malnutrition.25
Hence, the lack of protocols to evaluate and treat mal-
nutrition, as well as the limited involvement of healthcare
professionals in relation to early nutritional interventions are
important factors contributing to the high incidence of malnu-
trition found in the literature. Thus, diagnosis of malnutrition
and early intervention must be prioritized by all oncology
teams in an attempt to solve at least part of the problem.
Currently, the investments in nutrition in developed
countries have allowed earlier nutritional interventions and
treatment and, probably because of this, the prevalence
of malnutrition is lower in studies performed in those
countries.26 Hence, nutritional therapy protocols adapted to
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he reality of our population should be immediately imple-
ented in all Brazilian oncologic centers, so that these
atients have at least the chance of receiving adequate treat-
ent to avoid the need of reducing drug doses, delaying
hemotherapy cycles or surgical procedures, and decreasing
he risk of toxicity, infections and death.
onclusion
he prevalence of malnutrition in our study population was
lmost three times higher than in the general population of
razil. Accordingly, it is essential that policies that allow for
arlier diagnosis and implementation of nutritional interven-
ions and treatment are urgently required in order to offer
ore  effective treatment for pediatric cancer.
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